FSOAX
Price
$48.34
Change
+$0.54 (+1.13%)
Updated
Dec 20 closing price
VMVAX
Price
$84.58
Change
+$1.21 (+1.45%)
Updated
Dec 20 closing price
Ad is loading...

FSOAX vs VMVAX

Header iconFSOAX vs VMVAX Comparison
Open Charts FSOAX vs VMVAXBanner chart's image
Fidelity Advisor Value Strategies A
Price$48.34
Change+$0.54 (+1.13%)
VolumeN/A
CapitalizationN/A
Vanguard Mid-Cap Value Index Admiral
Price$84.58
Change+$1.21 (+1.45%)
VolumeN/A
CapitalizationN/A
FSOAX vs VMVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSOAX vs. VMVAX commentary
Dec 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSOAX is a Buy and VMVAX is a Hold.

FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 32.8B vs. FSOAX (2.35B). VMVAX pays higher dividends than FSOAX: VMVAX (2.14) vs FSOAX (0.54). FSOAX was incepted earlier than VMVAX: FSOAX (28 years) vs VMVAX (13 years). FSOAX is a more actively managed with annual turnover of: 59.00 vs. VMVAX (22.00). FSOAX has a lower initial minimum investment than VMVAX: FSOAX (0) vs VMVAX (3000). VMVAX annual gain was more profitable for investors over the last year : 13.95 vs. FSOAX (7.01). FSOAX return over 5 years is better than : 46.27 vs. VMVAX (37.82).
FSOAXVMVAXFSOAX / VMVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence28 years13 years-
Gain YTD8.48312.87166%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.35B32.8B7%
Annual Yield % from dividends0.542.1425%
Returns for 1 year7.0113.9550%
Returns for 3 years11.0012.2190%
Returns for 5 years46.2737.82122%
Returns for 10 years28.2384.5133%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IMCGX10.650.16
+1.53%
Transamerica Mid Cap Growth I
LAFTX18.900.20
+1.07%
Lord Abbett Affiliated R5
FSRAX8.320.04
+0.48%
Fidelity Advisor Strategic Real Ret A
SBHIX22.680.01
+0.04%
Saratoga Health & Biotechnology I
JEMNX9.63N/A
N/A
JHancock Emerging Markets Equity R4